We have examined the effects of the sterolbinding polyene antibiotics on macrophage tumoricidal capability. Incubation for 2 hr of activated macrophages from bacillus Calmette-Guerin-infected mice with amphotericin B at 0.5-2 ;&g/ml or amphotericin B methyl ester at 0.5-10 ,g/ml enhanced the capability of activated macrophages to kill 3T12 cells. These polyenes did not make normal or stimulated macrophages tumoricidal. Experiments with the ionophores gramicidin, alamethecin, nigericin, and valinomycin indicate that the ionophoretic properties of amphotericin B may not account for its enhancing effect on macrophage tumoricidal potential. Two polyenes with a smaller ring structure, filipin and pimaricin, were also ineffective suggesting that stereospecific modifications in membrane lipid organization underlie the enhancing effect of amphotericin B. The results suggest that the clinica efficacy of amphotericin B in promoting resistance to fungal disease and possibly to neoplasia may operate in part through potentiation of macrophage effector functions. Recent observations from this laboratory suggest that tumor cell killing by activated macrophages is highly dependent on the local environment in which macrophages and tumor cells coexist (1). Activated macrophages are tumoricidal in vitro when cultured in medium supplemented with fetal bovine serum, but these same macrophages generally do not kill tumor cells or do so only variably when cultured in medium supplemented with adult serums. We have termed such macrophages nontumoricidal activated macrophages. We have described several factors in normal serums, e.g., low density lipoprotein and a separate lower-molecular-weight serum factor, that regulate macrophage tumoricidal capability. Evidence was also presented that the modulation of macrophage tumoricidal potential by such serum factors may in part be dependent on cholesterol flux within macrophage plasma membranes (2). Based on these observations we have examined the effects of the sterol-binding polyene antibiotics on macrophage tumoricidal capability.
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METHODS AND MATERIALS Macrophage Monolayers. Adherent cell monolayers of normal, peptone-stimulated, or bacillus Calmette-Guerin (BCG)-activated peritoneal macrophages from C3H/HeJ (Jackson Laboratories), Ct3H/HeN, or C57bl/6 (Frederick Cancer Research Center Animal Facility) female mice were prepared as described (2, 3) .
Macrophage Activating Factor (MAF) Preparation. Lymphokine rich supernatants with MAF activity were supplied by Brice Weinberg. The supernatants were prepared by NaIO4 stimulation of peritoneal cells by a modification of the method of Bressler et al. (3, 4) . Although it is recognized that these supernatants may contain factors in addition to MAF, for this report the preparation is termed "MAF."
Cytotoxicity Assay. In vitro macrophage-mediated cytotoxicity toward tumorigenic 3T12 target cells was assayed by morphologic observation. After culture for 60 hr at 370 in humidified 95% air-5% C02, the 3T12 cells were fixed in methanol and stained with Giemsa. When tumor cells were stained immediately after attachment to a macrophage-free chamber surface, 33- (1) . The extent of inhibition of 3T12 cell growth or cell lysis by BCG macrophages exposed to a particular concentration of amphotericin B was also found to be variable, especially with the lower concentrations of the polyene antibiotics. For example, amphotericin B at 0.5 Mug/ml in 15 experiments induced a marked tumoricidal effect (<5 tumor cells per X300 field); but in 5 experiments only a weak cytocidal effect (5-S0 cells per field) was seen and on 2 occasions only a cytostatic effect (30-40 cells per field) was observed. Thus, the responsiveness of nontumoricidal activated macrophages to amphotericin B in terms of acquisition of cytotoxic capability also seems highly dependent on the preexisting tumoricidal potential of the BCG macrophage population before exposure to the polyene antibiotics. Moreover, normal or stimulated macrophages never attain the critical tumoricidal potential necessary for tumor cell killing in response to even maximal nontoxic concentrations of amphotericin B (8 ,ug/ml).
The experiment illustrated in Fig. 2 compares the effect of amphotericin B with that of amphotericin B methyl ester on the tumoricidal capability of BCG-activated macrophages. Again, the adherent peritoneal cell monolayers (--90% macrophages) were incubated for 2 hr at 370 with Dulbecco's modified Eagle's medium, amphotericin B, or amphotericin B methyl ester and then the polyenes were washed away before challenge with 3T12 cells. The BCG macrophages were nontumoricidal when cultured in 10% adult bovine serum (row A). Amphotericin B again induced the BCG macrophages to kill 3T12 cells in a dose-dependent manner ranging from a cytostatic effect (row B) to a marked cytocidal effect (rows C-D). At 4-8 ,g of amphotericin B per ml, the BCG macrophages were lysed and the 3T12 cells grew to a thick multilayer (rows F-H). Amphotericin B methyl ester similarly induced a BCG macrophage cytotoxic effect for the 3T12 target cells. In comparison to amphotericin B, the methyl ester derivative induced a full cytocidal effect over a broader concentration range (rows C-H) because this derivative was not toxic to BCG macrophages until concentrations >10 ,g/ml.
The amphotericin B and its methyl ester (Fig. 2) used in the experiments shown were dissolved in dimethyl sulfoxide at a final concentration of 0.5% (vol/vol) in culture medium. The dimethyl sulfoxide itself had no effect on macrophage tumor cell killing or 3T12 cell growth. Amphotericin B suspended in deoxycholate (Fungizone") was found to be equally potent. Fig. 3 A and B) . Nontoxic concentrations of amphotericin B alone also were insufficient to induce cytotoxic activity among the macrophage colonies (not shown). However, when MAF (1%, vol/vol) was combined with amphotericin B at 1 gg/ml and added to the cultures of 3T12 cells and cloned macrophages, the macrophage colonies maintained their integrity throughout a 60-hr assay and inhibited the growth of the 3T12 cells with which they were in contact (Fig. 3 C Comparison of Amphotericin B with Other Polyene Antibiotics for Their Effects on Macrophage Tumoricidal Capability. We have compared amphotericin B with two structurally different polyene antibiotics, filipin and pimaricin. Fig. 4 depicts a representative experiment comparing the tumoricidal inducing effects of these antibiotics on nontumoricidal activated macrophages. As shown in Fig. 4 , BCG macrophages are not generally spontaneously tumoricidal when cultured in 10% endotoxin-free adult bovine serum. The addition of amphotericin B throughout the 60-hr assay induced the BCG macrophages to kill 3T12 target cells (rows C-F). Filipin and pimaricin, however, in comparable molar concentrations did not enhance the tumoricidal capability of BCG macrophages. In other experiments, filipin and pimaricin in maximal nontoxic concentration (5 ,4g/ml and 25 ,gg/ml, respectively) were without effect on BCG macrophage tumoricidal potential. The polyenes in this experiment were dissolved in dimethyl sulfoxide which, as shown, did not account for the tumoricidal effect. The distinguishing structural features of these polyene antibiotics are important to consider. Amphotericin B and nystatin are 37-carbon macrolide ring structures containing seven and six double bonds, respectively, while filipin and pimaricin are 27-and 25-carbon rings, respectively, containing five double bonds (8, 9) . Filipin is neutral whereas the other polyenes have charged amphipathic structures. Within membranes, amphotericin B and nystatin form relatively small aggregates with membrane cholesterol. Evidence to date suggests that such polyene-cholesterol complexes within the inner and outer halves of the lipid bilayer interact to form transmembrane complexes (9) . These complexes organize in such a way as to create channels or pores selectively ionophoretic for small cations and anions (10, 11) . Analysis of channel selectivity in Acholeplasma laidlawii membranes indicate passage of Na+, K+, Li+, and glucose but not Ca2+, Mg2+, or sucrose through the pores (11, 12) . Pimaricin also binds to cholesterol within membranes with reportedly similar stoichiometry but does not induce selective membrane permeability changes. It has been proposed that the smaller dimension of the pimaricin molecule precludes the interaction of inner and outer membrane complexes and hence the formation of transmembrane channels (9) . Similarly, filipin binds to membrane cholesterol but, unlike the charged polyenes, forms large cholesterol aggregates visible by electron microscopy completely within the hydrophobic domains of the lipid bilayer. Filipin-cholesterol complexes are hence more disruptive to the membranes and, like pimaricin, do not induce selective permeability changes (9, 11) .
Influence of Other Ionophores on the Tumoricidal Capability of Activated Macrophages. We have considered whether the enhancing effect of amphotericin B is dependent upon its ionophoretic action. Such an explanation would account for the ineffectiveness of filipin and pimaricin because these polyenes are not ionophoretic. We have attempted to reproduce the amphotericin B effect with two polypeptide ionophores, gramicidin and alamethecin, whose action is dependent on membrane insertion and transmembrane channel formation but not upon binding of membrane cholesterol (13, 14) . Gramicidin has been shown to inhibit platelet vesicle transport of 5-hydroxytryptamine, a process dependent upon a transmembrane electrochemical gradient (15) . In artificial lipid bilayers gramicidin can dissipate such a gradient. Alamethecin likewise creates channels ionophoretic for cations and anions across artificial lipid bilayers and mitochondrial membranes (16) . In nontoxic concentrations (Table 1) gramicidin at 1-5 ,ug/ml and alamethecin at 1-60 ,ug/ml had no effect on BCG-activated macrophage tumoricidal capability. We have also examined two ionophores that function by a carrier type mechanism: nigericin and valinomycin. Valinomycin has been shown to induce K+ efflux across mouse macrophage plasma membranes (17) . Similarly, nigericin promotes K+ efflux and K+ for H+ exchange across biological membranes (18) . Again in nontoxic concentrations valinomycin (0.05-0.1 ,ug/ml) and nigericin (0.1-0.5 jig/ml) were without effect on BCG-activated macrophage tumoricidal potential. These results along with the results obtained with the several polyene antibiotics tested are summarized in Table 1 . We are not completely confident that any of the ionophores we have examined functionally reproduce the putative amphotericin B channels in macrophage plasma membranes and this explanation remains a possible one. Nevertheless, these experiments suggest that the ionophoretic properties of amphotericin B and nystatin do not account for their enhancing effect on macrophage tumoricidal potential. (19) (20) (21) . Activated macrophages are not necessarily tumoricidal, however. Recent experiments indicate that, at least from the point of view of populations of macrophages, macrophage differentiation toward tumoricidal effector cells is not an all-or-none phenomenon but rather is differentiation within a continuum of an increasing potential for tumor cell lysis. Within this continuum we have recognized several functional states: normal, stimulated, nontumoricidal activated, and tumoricidal activated macrophages (1). The observations reported here further define such a conceptual framework. Amphotericin B was found to induce the full expression of tumoricidal capability in previously nontumoricidal but activated macrophages, yet this agent had no such effect on either stimulated or normal macrophages. Similarly, amphotericin B did not make cloned macrophages kill tumor cells unless MAF was also present. Qualitative changes in macrophage physiology incurred in vivo during an immunologic response or in vitro after exposure to MAF appear to be a prerequisite to the expression of the amphotericin B effect. We suggest that such alterations in macrophage function concomitant with activation are dependent upon modifications in the lipid content and organization of macrophage plasma membranes. The observation that activated (either nontumoricidal or tumoricidal) macrophages were much more susceptible to lysis by amphotericin B than were normal macrophages (>1.5 ,ug/ml vs. >8 ,ug/ml) supports such a hypothesis. Other investigators have demonstrated that differential susceptibility to eukaryotic cell lysis by amphotericin B is dependent on membrane cholesterol/phospholipid molar ratios and phospholipid fatty acid compositions (22, 23 (26, 27) . Such modifications in membrane organization could be expected to modify membrane function as well. Although the precise structural changes after complex formation are unclear, these observations define an agent that directly induces macrophage tumor cell killing in vitro for which the complete molecular structure is known. If the Amphotericin B effect has a physiologic correlate, we suggest that penetration of macrophage membranes by hydrophobic terminal complement proteins might, instead of lysis, induce tumoricidal activity. We have no direct evidence that this is the case, however.
Amphotericin B is the major therapeutic agent used in systemic mycotic infections. Our results indicate that concentrations of amphotericin B in the range of those achieved with standard therapy and to which most fungi are susceptible (28) also enhance activated macrophage tumoricidal capability. In view of the known parallels between acquisition of enhanced microbicidal and tumoricidal capability by macrophages it is possible that part of the therapeutic effect of amphotericin B operates through potentiation of macrophage fungicidal capability.
Recent evidence indicates that amphotericin B either alone (29) or in combination with the cytotoxic drug 1,3-bis(2-chloroethyl)-l-nitrosourea may retard the progression of certain experimental and human tumors (30, 31) . Many tumors contain substantial proportions of macrophages (32, 33) , though the functional capabilities of such macrophages have not been widely studied. In at least one situation, progressing Moloney sarcomas, macrophages isolated from the tumors were found to be "primed" or nontumoricidal activated macrophages (34 (Fig. 2) on macrophage tumoricidal potential offers the possibility that this or other less toxic analogs of amphotericin B could be useful adjuvants in cancer thera-
